Monitor for follow-up data releases or peer-reviewed publication of CAPTAIN trial results, which could support reimbursement expansion or broader adoption. This event alone does not justify a trading move.
Price Chart
Executive Summary
Profound Medical announced that its TULSA-PRO system and the MRI-guided TULSA Procedure will be featured in multiple presentations at the 2026 Society of Interventional Radiology (SIR) Annual Meeting, including data from the CAPTAIN trial and real-world clinical experience. While the event increases visibility for the technology, no new clinical results, regulatory decisions, or commercial updates were disclosed. This is a promotional awareness event, not a material clinical or regulatory milestone.
Key Facts
- TULSA-PRO and TULSA Procedure will be highlighted in multiple oral and featured presentations at SIR 2026 Annual Meeting in Toronto (April 11–15, 2026).
- Presentations include CAPTAIN trial data (Level 1 evidence), real-world experience, and a meta-analysis of oncologic and functional outcomes.
- No new clinical data, FDA decisions, or commercial updates were released.
- The event is a scientific conference presentation, not a regulatory or commercial catalyst.
Financial Impact
Minimal near-term financial impact; potential long-term benefit from increased physician awareness and adoption.
Risk Factors
- Increased visibility does not guarantee adoption or reimbursement.
- Forward-looking statements in the release are speculative and not guaranteed.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3266591 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 4, 2026 28d ago | 8-K | $6.89 $5.81 | ▼ −15.67% | ▼ −14.47% | $5.85 (−15.09%) |
Sep 3, 2026 29d ago | 8-K | $6.80 $5.97 | ▼ −12.21% | ▼ −11.06% | $5.85 (−13.97%) |
Aug 17, 2026 6w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.85 (−10.69%) |
Aug 17, 2026 6w ago | 8-K | $6.55 $6.80 | ▲ +3.82% | ▲ +5.01% | $5.85 (−10.69%) |
Jul 24, 2026 10w ago | 8-K | $7.26 $7.25 | ▼ −0.14% | ▼ −0.51% | $5.85 (−19.42%) |
Jul 15, 2026 11w ago | 8-K | $6.96 $6.99 | ▲ +0.43% | ▲ +1.41% | $5.85 (−15.95%) |
May 14, 2026 20w ago | 8-K | $6.97 $6.83 | ▼ −2.01% | ▼ −2.97% | $5.85 (−16.07%) |
May 12, 2026 20w ago | S-3 | $7.10 $6.73 | ▼ −5.21% | ▼ −4.05% | $5.85 (−17.61%) |
Apr 16, 2026 24w ago | 8-K | $6.62 $6.75 | ▲ +1.96% | ▲ +0.98% | $5.85 (−11.63%) |
Apr 14, 2026 24w ago | 8-K | $6.26 $6.84 | ▲ +9.27% | ▲ +7.87% | $5.85 (−6.55%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access